John R Johnson

FDA drug approval summaries: pemetrexed (Alimta).

Richard Pazdur, R. Pazdur, John R. Johnson, 2004, The oncologist.

FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma.

Richard Pazdur, Robert Justice, R. Pazdur, 2007, The oncologist.

Approval summary: imatinib mesylate capsules for treatment of adult patients with newly diagnosed philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase.

Mark Rothmann, Richard Pazdur, Martin Cohen, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

End points and United States Food and Drug Administration approval of oncology drugs.

Richard Pazdur, R. Pazdur, Grant A. Williams, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Accelerated approval and oncology drug development timelines.

Richard Pazdur, Robert Justice, Rajeshwari Sridhara, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.